US regulators give nod for restarting use of Johnson & Johnson Covid vaccine
Image Credit: Star Tribune
The US drug regulators have approved restarting the use of the Johnson & Johnson coronavirus vaccine in the country. The rollout of the vaccine was paused after reports of blood clotting due to the use of the vaccine. "We have concluded that the known and potential benefits of the Janssen Covid-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older," said FDA head Janet Woodcock.